Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Robotic Cytoreduction and HIPEC for Gastric Cancer with Peritoneal Metastasis
NCT05753306Phase 2Recruiting
- Sponsor
- Mayo Clinic
- Start
- Apr 2023
- Primary completion
- Mar 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin, paclitaxel in gastric adenocarcinoma, peritoneal metastasis (PM), sponsored by Mayo Clinic. Started Apr 2023; status: recruiting.
02
Drugs
cisplatinpaclitaxel
03
Conditions
gastric adenocarcinomaperitoneal metastasis (PM)
Beyond the preview
Go deeper on NCT05753306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05753306.